On March 24, the Office of the Federal Register (Washington) made available for public inspection an Interim Final Rule with Request for Comments from the Drug Enforcement Administration (DEA), Department of Justice on Electronic Prescribing of Controlled Substances.
The Interim Final Rule specifies the rules that healthcare providers must follow in order to electronically prescribe controlled substances. Since DEA published the Notice of Proposed Rulemaking for e-prescribing of controlled substance, ONC, CMS, AHRQ and other HHS staff have worked closely with the organization to develop policies.
The document is expected to be published in the Federal Register on Wednesday, March 31 and will include a 60 day comment period. To view the Interim Final Rules, click here.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.